Identification of micro-RNA expression profile related to recurrence in women with ESMO low-risk endometrial cancer

被引：0
作者：
Tiphaine de Foucher
Maria Sbeih
Jenifer Uzan
Sofiane Bendifallah
Marine Lefevre
Nathalie Chabbert-Buffet
Selim Aractingi
Catherine Uzan
Issam Abd Alsalam
Rana Mitri
Romain H. Fontaine
Emile Daraï
Bassam Haddad
Céline Méhats
Marcos Ballester
Geoffroy Canlorbe
Cyril Touboul
机构：
[1] Sorbonne University,INSERM, UMR S 938
[2] Tenon University Hospital,Department of Obstetrics and Gynaecology
[3] Assistance Publique des Hôpitaux de Paris,Department of Obstetrics and Gynaecology
[4] Sorbonne University,INSERM, UMR S 707
[5] Creteil Intercommunal Hospital,Department of Pathology
[6] Université Paris Est,Department of Dermatology
[7] Paris XII,Department of Surgery and Oncological Gynaecology
[8] Sorbonne University,Department of Pathology
[9] Tenon University Hospital,Cochin Institute, Inserm U1016, CNRS 8104
[10] Assistance Publique des Hôpitaux de Paris,INSERM, UMR U965
[11] Sorbonne University,undefined
[12] Cochin University Hospital,undefined
[13] Assistance Publique des Hôpitaux de Paris,undefined
[14] University René Descartes,undefined
[15] Pitié-Salpétrière University Hospital,undefined
[16] Assistance Publique des Hôpitaux de Paris,undefined
[17] Sorbonne University,undefined
[18] Institut Universitaire de Cancérologie (IUC),undefined
[19] Creteil Intercommunal Hospital,undefined
[20] Université Paris Est,undefined
[21] Paris XII,undefined
[22] University René Descartes,undefined
[23] Paris Diderot University,undefined
来源：
Journal of Translational Medicine | / 16卷
关键词：
Low risk endometrial cancer; Recurrence; MicroRNAs; MicroRNA-184;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 517 条
  • [1] Ferlay J(2015)Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int J Cancer 136 E359-E386
  • [2] Soerjomataram I(2015)Cancer statistics, 2015 CA Cancer J Clin 65 5-29
  • [3] Dikshit R(2013)Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 24 vi33-38
  • [4] Eser S(2015)Just how accurate are the major risk stratification systems for early-stage endometrial cancer? Br J Cancer 112 793-1411
  • [5] Mathers C(2000)Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial Lancet. 355 1404-721
  • [6] Rebelo M(2012)The genomics and genetics of endometrial cancer Adv Genomics Genet. 2 33-401
  • [7] Siegel RL(2010)Mammalian microRNAs predominantly act to decrease target mRNA levels Nature 466 835-1523
  • [8] Miller KD(2013)microRNAs in human cancer Adv Exp Med Biol 774 1-112
  • [9] Jemal A(2014)Identification of endometrioid endometrial carcinoma-associated microRNAs in tissue and plasma Gynecol Oncol 132 715-W97
  • [10] Colombo N(2016)Micro-RNA signature of lymphovascular space involvement in type 1 endometrial cancer Histol Histopathol 32 11859-280
12345678910